Letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by P. Barrière, S. Hamamah, E. Arbo, C. Avril, B. Salle, J.-L. Pouly, et al. (J Gynecol Obstet Hum Reprod. 2023;52(1):102510)
other
OA: green
CC-BY-4.0
AI-generated summary
This letter to the editor responds to a real-world study comparing a biosimilar rFSH against the originator, discussing its findings in the context of differing rFSH starting doses.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-06-21T06:12:49.409960+00:00
- pubmed
- last seen: 2026-06-21T06:11:38.412952+00:00
- unpaywall
- last seen: 2026-05-15T02:00:00.661756+00:00
License: CC-BY-4.0
· commercial use OK
· attribution required
Courtesy of the U.S. National Library of Medicine
Courtesy of the U.S. National Library of Medicine